Science Spotlight: What’s Next in Cancer Immunotherapy According to International Immunotherapy Leader, Dr. Jedd Wolchok

Share
Print
Jedd Wolchok, MD, PhD

Jedd Wolchok, MD, PhD

Join Jedd Wolchok, MD, PhD, during the June 24 edition of “MSK Science Spotlight” for a discussion on “Enabling Costimulatory Pathways as a Next Step for Cancer Immunotherapy.” Dr. Wolchok serves as the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation, Chief of the Immuno-Oncology Service, Director of the Parker Institute for Cancer Immunotherapy at MSK; and Associate Director of the Ludwig Center for Cancer Immunotherapy. As head of the Jedd Wolchok Lab, the goal of Dr. Wolchok’s research is to develop and implement new ways to use the immune system to treat cancer. Dr. Wolchok, a world-renowned leader in immunotherapy, was recently named a recipient of the AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research.

MSK Science Spotlight
 “MSK Science Spotlight” seminars take place every Monday and Wednesday at 4:30 pm ET and are 60 minutes, including 15 minutes for Q&A. Detailed information about seminar speakers, dates, and times as well as live streams and recorded video are available here.